G试验在侵袭性真菌病诊断中的最新进展

doi:10.3969/j.issn.1673-8640.2019.09.021

摘要/Abstract

摘要：

近30年来,侵袭性真菌病（IFD）的发生率和死亡率有逐年上升的趋势。IFD发病隐匿、死亡率高,且治疗手段有限,敏感且特异的实验室诊断方法对疾病的预防和治疗具有十分重要的意义。G试验作为一种快速、无创的检验方法,在IFD诊断中的作用日益明显。文章对近5年G试验在IFD诊断相关领域的主要进展进行综述。

关键词: G试验, 1,3-β-D-葡聚糖, 侵袭性真菌病, 诊断

Abstract:

In the past 30 years,the morbidity and mortality of invasive fungal diseases（IFD） are increasing. Considering the non-specific manifestations,limited treatment and high mortality,sensitive and specific laboratory diagnostic methods are of significance to prevent and treat IFD. As a fast and non-invasive method,G-test plays a role in the diagnosis of IFD. The main progresses of G-test in the last 5 years are focused in this review.

Key words: G-test, 1,3-β-D-glucan, Invasive fungal disease, Diagnosis

中图分类号:

R446.1

李占甲, 翟红岩, 陈水平. G试验在侵袭性真菌病诊断中的最新进展[J]. 检验医学, 2019, 34(9): 859-863.

LI Zhanjia, ZHAI Hongyan, CHEN Shuiping. Research progress of G-test in the diagnosis of invasive fungal diseases[J]. Laboratory Medicine, 2019, 34(9): 859-863.

参考文献 49

[1]	中国侵袭性真菌感染工作组. 血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则(第五次修订版)[J]. 中华内科杂志,2017,56(6):453-459.
[2]	LIEPINS J,KOVAOVA E,SHVIRKSTS K,et al.Drying enhances immunoactivity of spent brewer's yeast cell wall β-d-glucans[J]. J Biotechnol,2015,206:12-16.
[3]	TRAN T,BEAL S G.Application of the 1,3-beta-D-glucan(fungitell) assay in the diagnosis of invasive fungal infections[J]. Arch Pathol Lab Med,2016,140(2):181-185.
[4]	薛知信,刘娟娟,王保学,等. 碱处理法提高血清1,3-β-D-葡聚糖检测的特异性[J]. 检验医学,2017,32(1):48-51.
[5]	MIKULSKA M,GIACOBBE D R,FURFARO E,et al. Lower sensitivity of serum(1,3)-β-d-glucan for the diagnosis of candidaemia due to Candida parapsilosis[J]. Clin Microbiol Infect,2016,22(7):646.e5-58.
[6]	DE PAUW B,WALSH T J,DONNELLY J P,et al.Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group(EORTC/MSG) Consensus Group[J]. Clin Infect Dis,2008,46(12):1813-1821.
[7]	KARAGEORGOPOULOS D E,VOULOUMANOU E K,NTZIORA F,et al.β-D-glucan assay for the diagnosis of invasive fungal infections:a meta-analysis[J]. Clin Infect Dis,2011,52(6):750-770.
[8]	LEVESQUE E,RIZK F,NOORAH Z,et al. Detection of(1,3)-β-d-glucan for the diagnosis of invasive fungal infection in liver transplant recipients[J]. Int J Mol Sci,2017,18(4):pii:E862.
[9]	REISCHIES F M,PRATTES J,WOELFLER A,et al.Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation[J]. Transpl Infect Dis,2016,18(3):466-470.
[10]	TALENTO A F,DUNNE K,JOYCE E A,et al.A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit[J]. J Crit Care,2017,40:119-127.
[11]	LAMOTH F.Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis[J]. Journal of Fungi,2016,2(3):22.
[12]	ALEXANDER B D,SMITH P B,DAVIS R D,et al.The (1,3)){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation[J]. J Clin Microbiol,2010,48(11):4083-4088.
[13]	SON H J,SUNG H,PARK S Y,et al.Diagnostic performance of the(1-3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis,aspergillosis,mucormycosis,and tuberculosis,and healthy volunteers[J]. PLoS One,2017,12(11):e0188860.
[14]	OSTROSKY-ZEICHNER L,ALEXANDER B D,KETT D H,et al.Multicenter clinical evaluation of the(1→3)-beta-D-glucan assay as an aid to diagnosis of fungal infections in humans[J]. Clin Infect Dis,2005,41(5):654-659.
[15]	HE S,HANG J P,ZHANG L,et al.A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection:focus on cutoff levels[J]. J Microbiol Immunol Infect,2015,48(4):351-361.
[16]	SHABAAN A E,ELBAZ L M,EL-EMSHATY W M,et al. Role of serum (1,3)-β-d-glucan assay in early diagnosis of invasive fungal infections in a neonatal intensive care unit[J]. J Pediatr(Rio J),2018,94(5):559-565.
[17]	OBAYASHI T,NEGISHI K,SUZUKI T,et al.Reappraisal of the Serum(1→3)-beta-D-glucan assay for the diagnosis of invasive fungal infections-a study based on autopsy cases from 6 years[J]. Clin Infect Dis,2008,46(12):1864-1870.
[18]	SMITH P B,BENJAMIN DK Jr,ALEXANDER B D,et al.Quantification of 1,3-beta-D-glucan levels in children:preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting[J]. Clin Vaccine Immunol,2007,7(14):924-925.
[19]	GOUDJIL S,KONGOLO G,DUSOL L,et al.(1-3)-β-D-glucan levels in candidiasis infections in the critically ill neonate[J]. J Matern Fetal Neonatal Med,2012,26(1):44-48.
[20]	CALITRI C,CAVIGLIA I,CANGEMI G,et al.Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children[J]. Mycoses,2017,60(12):789-795.
[21]	HARON E,VARTIVARIAN S,ANAISSIE E,et al.Primary Candida pneumonia. Experience at a large cancer center and review of the literature[J]. Medicine(Baltimore),1993,72(3):137-142.
[22]	PAPPAS P G,KAUFFMAN C A,ANDES D R,et al.Clinical practice guidelines for the management of candidiasis:2009 update by the Infectious Diseases Society of America[J]. Clin Infect Dis,2009,48(5):503-535.
[23]	SU K C,CHOU K T,HSIAO Y H,et al.Measuring(1,3)-β-D-glucan in tracheal aspirate,bronchoalveolar lavage fluid,and serum for detection of suspected Candida pneumonia in immunocompromised and critically ill patients:a prospective observational study[J]. BMC Infect Dis,2017,17(1):252.
[24]	SHI X Y,LIU Y,GU X M,et al.Diagnostic value of (1→3)-β-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease:a meta-analysis[J]. Respir Medicine,2016,117:48-53.
[25]	URABE N,SAKAMOTO S,SANO G,et al.Usefulness of two aspergillus PCR assays and aspergillus galactomannan and β-d-glucan testing of bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis[J]. J Clin Microbiol,2017,55(6):1738-1746.
[26]	ROSE S R,VALLABHAJOSYULA S,VELEZ M G,et al.The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections[J]. J Infect,2014,69(3):278-283.
[27]	LYONS J L,THAKUR K T,LEE R,et al.Utility of measuring(1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection[J]. J Clin Microbiol,2015,53(1):319-322.
[28]	BROWN G D,GORDON S.Immune recognition of fungal beta-glucans[J]. Cell Microbiol,2005,7(4):471-479.
[29]	LITVINTSEVA A P,LINDSLEY M D,GADE L,et al.Utility of(1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections[J]. Clin Infect Dis,2014,58(5):622-630.
[30]	ODABASI Z,PAETZNICK V L,RODRIGUEZ J R,et al.Differences in beta-glucan levels in culture supernatants of a variety of fungi[J]. Med Mycol,2006,44(3):267-272.
[31]	RHEIN J,BAHR N C,MORAWSKI B M,et al. Detection of high cerebrospinal fluid levels of (1→3)-β-d-glucan in cryptococcal meningitis[J]. pen Forum Infect Dis,2014,1(3):ofu105.
[32]	SCHELENZ S,BARNES R A,BARTON R C,et al.British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases[J]. Lancet Infect Dis,2015,15(4):461-474.
[33]	ODABASI Z,MATTIUZZI G,ESTEY E,et al.Beta-D-glucan as a diagnostic adjunct for invasive fungal infections:validation,cutoff development,and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome[J]. Clin Infect Dis,2004,39(2):199-205.
[34]	TISSOT F,LAMOTH F,HAUSER P M,et al.β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis[J]. Am J Respir Crit Care Med,2013,188(9):1100-1109.
[35]	PAZOS C,PONTÓN J,DEL PALACIO A. Contribution of(1→3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients:a comparison with serial screening for circulating galactomannan[J]. J Clin Microbiol,2005,1(43):299-305.
[36]	ELLIS M,AL-RAMADI B,FINKELMAN M,et al.Assessment of the clinical utility of serial -D-glucan concentrations in patients with persistent neutropenic fever[J]. J Med Microbiol,2008,57(Pt 3):287-295.
[37]	GIACOBBE D R,MIKULSKA M,TUMBARELLO M,et al.Combined use of serum(1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units[J]. Crit Care,2017,21(1):176.
[38]	KANDA H,KUBO K,HAMASAKI K,et al.Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan level[J]. Kidney Int,2001,60(1):319-323.
[39]	PICKERING J W,SANT H W,BOWLES C A,et al.Evaluation of a(1→3)-beta-D-glucan assay for diagnosis of invasive fungal infections[J]. J Clin Microbiol,2005,43(12):5957-5962.
[40]	LO CASCIO G,KONCAN R,STRINGARI G,et al.Interference of confounding factors on the use of(1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit[J]. Eur J Clin Microbiol Infect Dis,2015,34(2):357-365.
[41]	WASSER S P.Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides[J]. Appl Microbiol Biotechnol,2002,60(3):258-274.
[42]	ZHENG F,ZHA H,YANG D,et al.Diagnostic values and limitations of(1,3)-β-D-glucans and galactomannan assays for invasive fungal infection in patients admitted to pediatric intensive care unit[J]. Mycopathologia,2017,182(3-4):331-338.
[43]	HASHIMOTO N,MORI T,HASHIDA R,et al.False-positive serum(1,3)-β-D-glucan elevation due to intake of seaweed in a hematopoietic stem cell transplant recipient[J]. Transpl Infect Dis,2017,19(2):12653.
[44]	MENNINK-KERSTEN M,RUEGEBRINK D,VERWEIJ P E.Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity[J]. Clin Infect Dis,2008,46(12):1930-1931.
[45]	ALBERT O,TOUBAS D,STRADY C,et al.Reactivity of(1→3)-β-d-glucan assay in bacterial bloodstream infections[J]. Eur J Clin Microbiol Infect Dis,2011,30(11):1453-1460.
[46]	KONCAN R,FAVUZZI V,LIGOZZI M,et al.Cross-reactivity of Nocardia spp. in the fungal(1-3)-β-d-glucan assay performed on cerebral spinal fluid[J]. Diagn Microbiol Infect Dis,2015,81(2):94-95.
[47]	MARTY F M,LOWRY C M,LEMPITSKI S J,et al.Reactivity of(1→3)-beta-d-glucan assay with commonly used intravenous antimicrobials[J]. Antimicrob Agents Chemother,2006,50(10):3450-3453.
[48]	MENNINK-KERSTEN M A,WARRIS A,VERWEIJ P E. 1,3-Beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid[J]. N Engl J Med,2006,354(26):2834-2835.
[49]	GUITARD J,TABONE M D,SENGHOR Y,et al.Detection of β-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy[J]. J Infect,2016,73(6):607-615.